A Drug Interaction Study of KW-6356 and Clarithromycin or Rifampicin
Status:
Completed
Trial end date:
2019-11-19
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effects of CYP3A4/5 inhibitor or inducer on
the pharmacokinetics of KW-6356 when CYP3A4/5 inhibitor or inducer is orally administered to
healthy Japanese men for 7 days.